Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-089224
Filing Date
2025-06-24
Accepted
2025-06-24 08:00:38
Documents
2
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 6-K press_release_june_24_20.htm 6-K 25516
2 EX-99.1 ipa-ex99_1.htm EX-99.1 37895
  Complete submission text file 0000950170-25-089224.txt   64466
Mailing Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701
Business Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 251066708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)